Can the occurrence of gastrointestinal bleeding in nonpulsatile left ventricular assist device patients provide clues for the reversal of arteriosclerosis?

Cardiol Clin. 2011 Nov;29(4):641-5. doi: 10.1016/j.ccl.2011.08.010.

Abstract

This article is written not only to explore the deleterious effects of nonpulsatile flow (namely, gastrointestinal [GI] bleeding), but also to propose the novel concept that deliberate induction of nonpulsatile flow might be harnessed to produce beneficial remodeling in arteriosclerotic arteries. Continuous-flow left ventricular assist devices have proven their efficacy in the treatment of end-stage heart disease. They are a reliable option in bridge-to-transplant and destination therapy. An enigmatic consequence of this therapy has been occult GI bleeding.

MeSH terms

  • Arteriosclerosis / physiopathology
  • Arteriosclerosis / prevention & control*
  • Blood Circulation / physiology
  • Blood Pressure / physiology
  • Gastrointestinal Hemorrhage / etiology*
  • Heart Failure / physiopathology
  • Heart Failure / therapy*
  • Heart-Assist Devices / adverse effects*
  • Hemodynamics / physiology
  • Hemostasis / physiology
  • Humans
  • Treatment Outcome
  • von Willebrand Factor / metabolism

Substances

  • von Willebrand Factor